Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy

Journal of Pharmaceutical Sciences - United States
doi 10.1016/j.xphs.2019.02.022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

AR101 Oral Immunotherapy for Peanut Allergy

Pediatrics
Child HealthPediatricsPerinatology
2019English

Peanut Allergy and Oral Immunotherapy

Hong Kong Medical Journal
Medicine
2019English

Evaluation of Peanut Sublingual Immunotherapy for Peanut Allergy: A Pilot Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Long Term Follow-Up of Oral and Sublingual Immunotherapy for Peanut Allergy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Oral Immunotherapy for Food Allergy

Journal of Investigational Allergology and Clinical Immunology
AllergyImmunology
2017English

Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Young Children

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Oral Immunotherapy to Peanut in Children With Mild and Moderate Peanut Allergy Results in Long Term Tolerance

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Intralymphatic Immunotherapy for Peanut Allergy: A Pilot Study of Three Patients

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Safety and Tolerability of a Novel Peptide-Based Immunotherapy for Peanut Allergy

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy